We provide you with 20 years of free, institutional-grade data for PHIO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PHIO. Explore the full financial landscape of PHIO stock.
| Reported Date | CIK | Ticker | Type |
|---|
Phio Pharmaceuticals Corp(NASDAQ:PHIO) 
Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762, which targets the checkpoint protein PD-1 that pre...
Website: https://phiopharma.com/
Founded: 2011
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about PHIO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.